Orwitaz P 4000mg/500mg Injection
Marketer
Orwin Biotech Pvt. Ltd.
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Orwitaz P 4000mg/500mg Injection
Azithromycin/sulbactam 4000mg/500mg injection is a dual-antibiotic formulation indicated for diverse bacterial infections. Its mechanism involves microbial eradication. Administration should always be performed by a qualified medical practitioner; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on individual health status and infection severity. Adherence to the prescribed regimen is crucial. Potential side effects may include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions to your doctor; adjustments to the medication or alternative therapies may be necessary. Under medical guidance, this medication is generally considered safe during pregnancy and lactation.
Primary Ingredients of Orwitaz P 4000mg/500mg Injection
No text was provided to rewrite.
Uses of Orwitaz P 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Orwitaz P 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Orwitaz P 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Orwitaz P 4000mg/500mg Injection:
The medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Orwitaz P 4000mg/500mg Injection works:
Orwitaz P Injection (4000mg/500mg) combines piperacillin, a bacterium-fighting antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Orwitaz P 4000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Orwitaz P (4000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Orwitaz P (4000mg/500mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Orwitaz P 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
The administration of Orwitaz P 4000mg/500mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Orwitaz P 4000mg/500mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Orwitaz P 4000mg/500mg Injection in patients with liver impairment appears to pose minimal risk. Preliminary evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Orwitaz P 4000mg/500mg Injection :
Should you inadvertently skip a dose of Orwitaz P 4000mg/500mg Injection, seek medical advice from your physician.
Facts to Know About Orwitaz P 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently